Conferences Deals Trial results 17 September 2024 ESMO 2024 – Bristol abandonment overshadows Immatics Read more
Conferences 22 July 2024 ESMO 2024 preview – Summit and BioNTech battle again The companies’ PD-(L)1 x VEGF bispecifics will clash in triple-negative breast cancer. Read more